Product NDC: | 0067-6318 |
Proprietary Name: | THERAFLU |
Non Proprietary Name: | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE |
Active Ingredient(s): | 650; 25; 10 mg/1; mg/1; mg/1 & nbsp; ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0067-6318 |
Labeler Name: | Novartis Consumer Health, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20090810 |
Package NDC: | 0067-6318-06 |
Package Description: | 6 POWDER, FOR SOLUTION in 1 CARTON (0067-6318-06) |
NDC Code | 0067-6318-06 |
Proprietary Name | THERAFLU |
Package Description | 6 POWDER, FOR SOLUTION in 1 CARTON (0067-6318-06) |
Product NDC | 0067-6318 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE |
Dosage Form Name | POWDER, FOR SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20090810 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Novartis Consumer Health, Inc. |
Substance Name | ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 650; 25; 10 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |